Ac immune to highlight first-in-class alzheimer's disease vaccine programs at upcoming investor conferences

Lausanne, switzerland, may 20, 2021 (globe newswire) -- ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that it will participate in the ubs global healthcare virtual conference and the jefferies virtual healthcare conference, taking place may 24-26, 2021 and june 1-4, 2021, respectively.
ACIU Ratings Summary
ACIU Quant Ranking